Leadership & Pay ·
Teva appoints Dr. David J. Brailer to its Board of Directors
TEVATeva Pharmaceutical Industries Ltd
On October 27, 2026, Teva Pharmaceutical Industries Ltd.'s Board elected Dr. David J. Brailer as an independent director, effective November 3, 2026. He will serve until the 2027 annual meeting and is expected to join the Human Resources and Compensation and Compliance Committees. Dr. Brailer brings extensive health-tech experience, having served as CEO of medem.ai and previously as Chief Health Officer at The Cigna Group. He joins from a background including leadership roles at Health Evolution and directorships at Prolacta Bioscience and Walgreens Boots Alliance. Teva Pharmaceutical Industries Ltd. is a global manufacturer and marketer of generic medicines.